All Industries

Elixir Energy advances gas projects in Queensland and Mongolia

ELIXIR ENERGY LIMITED

Elixir Energy Ltd (ASX:EXR) managing director Neil Young sits down with Proactive’s Jonathan Jackson to discuss the significant strides the company is making in de-risking its gas projects in Queensland and Mongolia. Its Daydream-2 well at the Grandis Project in Queensland is set to undergo rigorous stimulation and flow testing activities, managed by Halliburton, through mid-year. This activity in the Taroom Trough is generating increasing interest in the gas sector. In parallel, Elixir continues to progress its Nomgon Pilot Project in Mongolia. The focus remains on depressurising the gas-bearing coal reservoir, a crucial step achieved through the continuous extraction of water. This dual-front approach underlines Elixir Energy's commitment to meeting its core de-risking objectives for both projects. Young said: “We are pleased that operations at both of our large gas projects in Queensland and Mongolia are on track to meet their core de-risking objectives. "The Daydream-2 well at Grandis will be the scene of intense activity through to around the middle of the year as we now move into the key stimulation and flow testing phases. "Given this, we are very pleased to note that the current activities by a range of Operators in the Taroom Trough is drawing more and more gas industry attention.” Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

March 19, 2024 01:00 PM Eastern Daylight Time

Video

OzAurum to start drilling at Boca Rica Lithium Project

OZAURUM RESOURCES LIMITED

OzAurum Resources Ltd (ASX:OZM) CEO and managing director Andrew Pumphrey sits down with Proactive’s Jonathan Jackson to discuss an upcoming drilling program at Boca Rica Lithium Project in Brazil, following the identification of a spodumene zone. The company plans to start drilling in the next three to four weeks, contingent on weather and the receipt of environmental permits. Pumphrey emphasised the project's potential for a major lithium discovery, highlighting the strategic scale of the site and the comprehensive fieldwork conducted in Brazil. Besides Boca Rica, OzAurum is actively pursuing other lithium opportunities and is engaged in discussions for additional acquisitions. The company also has interest in niobium and rare earth element (REE) opportunities in Brazil, and has lodged applications for 50,000 hectares of tenure prospective for niobium and REE near known Brazilian carbonatite complexes. Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

March 19, 2024 12:35 PM Eastern Daylight Time

Video

Celsius Resources granted major permit; paves way for copper development

CELSIUS RESOURCES LIMITED

In what is perhaps the company’s biggest milestone to date, Celsius Resources Ltd (ASX:CLA) managing director Peter Hume sits down with Proactive’s Jonathan Jackson to discuss the importance of its Philippine subsidiary, Makilala Mining Company, Inc. (MMCI), being granted a Mineral Production Sharing Agreement (MPSA) for the Maalinao-Caigutan-Biyog Mining Project (MCB). Issued by the Philippine Department of Environment and Natural Resources on March 14, 2024, this permit is valid for 25 years and renewable for another 25 and represents a pivotal step for Celsius in transitioning from an exploration entity to a mineral resource developer and future mine operator. The MPSA, the first copper project approval in the Philippines in the last 15 years, endows MMCI with exclusive rights for the exploration, development, and production of copper and associated minerals within the 2,500-hectare contract area. This development catalyses the MCB project's progression towards operational status. Hume lauded the achievement as a testament to the diligence of the in-country team and a critical juncture in the company’s evolution. Granting of the permit is expected to stimulate financial investments, with Celsius already engaging with potential backers. With the permit secured, Celsius is set to finalise funding mechanisms, advancing the MCB project into its next developmental phase. Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

March 19, 2024 11:15 AM Eastern Daylight Time

Video

Alkane Resources nears Kaiser resource upgrade with record gold hits

Alkane Resources Limited

On the brink of significantly upgrading the mineral resource estimate for its Kaiser deposit in the Northern Molong Porphyry Project in New South Wales, Alkane Resources Ltd (ASX:ALK) managing director Nic Earner takes Proactive’s Jonathan Jackson through the latest drilling results. Alkane has delivered the highest gold grades observed to date at the site, with an exceptional intercept of 8.6 metres at 14.8 g/t gold equivalent, including segments of 3.5 metres at 31.3 g/t and 1 metre at 62.2 g/t gold equivalent. Earner highlights the remarkable findings from the final 12,000-metre round of drilling, which confirmed the presence of high-grade sections and a 'Boda' style breccia, intensifying the deposit’s prospects. With these results, Alkane is poised to release an updated Kaiser resource estimate in April, enhancing the already impressive Boda resource figures. Looking forward, the company is conducting a scoping study to assess the mining viability of both Boda and Kaiser, with results expected in the June quarter. Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

March 19, 2024 11:15 AM Eastern Daylight Time

Video

Ionic Rare Earths on track to be first ASX producer of rare earth oxides from recycled wind turbines

IONIC RARE EARTHS LIMITED

Ionic Rare Earths Ltd (ASX:IXR) managing director Tim Harrison joins Jonathan Jackson in the Proactive studio as the company sets itself to become the first ASX-listed company to produce magnet rare earth oxides (REOs) from recycled wind turbines. Harrison highlights the company's journey towards becoming a major producer of recycled separated magnet REO, a milestone that positions IonicRE as a frontrunner in establishing a sustainable supply chain outside China. IonicRE's innovative approach targets the recycling of permanent magnets from decommissioned wind turbines, a market that is rapidly expanding, particularly in Europe. The company's Belfast Demonstration Plant is making significant strides in magnet REO production, with a focus on the processing of NdPr/DyHo separation following the successful creation of mixed REO products. In 2023, the European wind energy sector saw the decommissioning of 736 MW of power across nine countries, indicating a substantial opportunity for IonicRE's recycling initiative. With more than 3,000 wind turbines in Ireland alone, IonicRE is at the forefront of delivering a secure, clean and green supply chain, crucial for the wind farm industry and broader renewable energy sectors in achieving global decarbonisation goals. The company's executive chairman Brett Lynch said: “This is a major step forward in the development of an ex-China supply chain, with IonicRE offering the potential to become the first and only REO recycler from wind turbine magnets in the Western world. “The size of the prize is significant, given the tremendous rate of growth in the wind turbine market, particularly given our proximity to the UK and Northern Ireland wind farms market with the Port of Belfast on our doorstep. "With over 3,000 wind turbines located across the island of Ireland, the opportunity is compelling." Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

March 19, 2024 11:00 AM Eastern Daylight Time

Video

Kuehn Law Encourages FUSN, KAMN, DRQ, and VZIO Investors to Contact Law Firm

Kuehn Law

Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) click to participate Fusion Pharmaceuticals has agreed to be acquired by AstraZeneca. Under the agreement, shareholders of Fusion will be entitled to a payment of $21.00 per share in cash plus a non-transferable CVR of $3.00. Kaman Corp. (NYSE: KAMN) click to participate Kaman has reached a deal to be quired by Arcline Investment Management, L.P. In this deal, each Kaman shareholder will be paid $46.00 per share in a cash transaction. Dril-Quip, Inc. (NYSE: DRQ) click to participate Dril-Quip has agreed to merge with Innovex Downhole Solutions. Under the agreement, shareholders of Dril-Quip will own approximately 52% of the combined company. VIZIO Holding Corp. (NYSE: VZIO) click to participate VIZIO has agreed to be acquired by Walmart. Under the agreement, shareholders of VIZIO will be entitled to $11.50 per share in cash. Why Your Participation Matters: As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future. ™ How to Get Involved: Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law. Attorney advertising. Prior results do not guarantee similar outcomes. Contact Details Kuehn Law, PLLC Justin Kuehn, Esq +1 833-672-0814 justin@kuehn.law Company Website https://www.kuehn.law/

March 19, 2024 10:55 AM Eastern Daylight Time

Leading Consumer Directed Health Provider Navia Benefit Solutions Partners with Penelope, a Modern Retirement Savings Platform, to Offer a Comprehensive Health & Wealth Benefit Offering

Penelope

Navia Benefit Solutions, a nationwide consumer-directed benefits provider of health, wealth, and compliance solutions, today announced a strategic partnership with Penelope, a premier retirement savings platform, to offer white-label 401(k) plan offerings. The partnership marks Penelope’s entry into the third-party administrator space. By offering a white-label solution, non-retirement third-party administrators can grow their businesses and deepen their existing relationships while also maintaining a cohesive brand experience. Penelope’s white-label plans empower Navia to provide a fuller, more streamlined suite of integrated benefit offerings, which include flexible spending accounts, health savings accounts, health reimbursement arrangements, commuter plans, wellness plans, and COBRA administration. “Legacy platforms have made it difficult to offer comprehensive health and wealth solutions,” said Hilarie Aitken, chief executive officer of Navia. “Penelope’s new technology allows us to provide a holistic package that reaches across the benefit spectrum and creates a seamless, more efficient experience for our clients.” Penelope launched in 2022 to provide simplified, affordable, and easy-to-manage retirement plans directly to business owners and has since expanded its offerings to serve this new market segment. “The affinity we have for Navia stems from our shared mission of taking away the complexity and burden of providing necessary benefits to American workers,” said Jean Smart, founder and chief executive officer of Penelope. “Each of our companies is dedicated to empowering the market to provide the best and most effective benefit solutions–solutions that improve health, and secure financial futures.” States across the country are enacting various legislation designed to encourage businesses to offer retirement plans. Currently, 18 states require businesses of all sizes to offer IRAs or other retirement solutions to their employees, with further pending legislation. “Navia and Penelope understand the unique challenges of business owners and benefits executives, and both companies are poised to lower the barriers to implementing effective retirement plans,” said Jennifer Thomas, executive vice president of TRI-AD, a subsidiary of Navia. “Our shared values make this the perfect solution as we expand access to easy-to-employ, modern wealth benefits, and close the retirement gap.” About Navia Benefits Solutions Navia is a national, consumer-directed benefits provider serving 10,000+ employers across all 50 states. The company provides comprehensive health, wealth, and compliance solutions to employers and consumers, and offers industry-leading customer service, communications, and technology. Founded in 1989, Navia began as Flex-Plan Services, and over the years has grown into one of the nation’s premier benefit providers. Navia offers FSA, HSA, HRA, Commuter, Lifestyle, Retirement, Benefit Administration, Education, COBRA, and other benefits. For more information visit www.naviabenefits.com. About Penelope Penelope is the retirement savings platform for businesses, independent financial advisors, and third-party administrators looking to provide a secure retirement for the 60 million Americans who work in small businesses. Through a low-cost 401(k) subscription model, Penelope provides affordable and streamlined savings vehicles for small business owners and their employees without hidden charges, hassle, or unnecessary jargon. Penelope’s intuitive technology platform automates employee investing, streamlines costs and paperwork, and provides learning tools for employees. For more information, visit www.Penelope.co. Contact Details For Penelope Peter Page ppage@vocatusllc.com Company Website https://penelope.co/

March 19, 2024 10:00 AM Eastern Daylight Time

ZEAKAL DELIVERS SYNERGISTIC INNOVATION TO ENHANCE SUSTAINABILITY OF CORN PRODUCTION

ZeaKal

ZeaKal today announced the successful development of its groundbreaking PhotoSeed™ technology in corn, improving the crop’s oil and sustainability profile without compromising yield or protein. With the immediate implementation of PhotoSeed corn’s route to market, ZeaKal aims to redefine the value proposition of this vital crop for growers, industry, and consumers alike. In first year replicated field trials, PhotoSeed increased corn oil composition by an average of 23 percent. PhotoSeed enhances a plant’s photosynthetic capacity, capturing more CO2 and sunlight. This additional carbon capture increases oil production without taking away the energy necessary to maintain modern yields. Despite tremendous demand, previous efforts to boost oil content without compromising yield have eluded agribusinesses. ZeaKal now introduces the first viable solution. Han Chen, co-founder and CEO of ZeaKal, emphasized the imperative for accelerated innovation to meet the escalating demand for sustainable corn oil production. "This trait technology allows us to elevate the overall value of U.S. corn and creates a differentiated, value-added product that addresses industry demand," said Chen. “U.S. farmers need innovation faster if we hope to compete in a challenging global commodity market. While we cannot change sunlight availability and geography for our growers, we can bring a latitude advantage to them through genetics.” Corn, occupying 90 million acres in the United States and ranking among the most crucial crops globally, serves as a cornerstone for food, feed, and fuel feedstocks. The FAO forecasts a 70% surge in global demand for sustainable food and feed, and other projections indicate that renewables will constitute 43% of total energy within a decade. Together, this underscores the urgency for plant-based energy, which offers inherent benefits for aviation fuel and renewable diesel that other innovations cannot offer. Expanded Gro Alliance Partnership Accelerates Farmers’ Access to PhotoSeed Corn Hybrids In 2022, ZeaKal set a path to restore value across the soy supply chain by creating a closed loop U.S. system to capture and share premiums from better composition, processing advantages, and improved sustainability metrics with farmers and producers – called the NewType model. PhotoSeed corn follows the model’s success starting with integration into Gro Alliance’s extensive germplasm collection, breeding program, and fully integrated seed production. “For too long, extended periods of depressed commodity prices coupled with rising input costs have magnified risk for U.S. farmers. With ZeaKal 's breakthrough technology and our expanded capacity and partnerships, we are setting our sight on the better seed for the entire value chain; farmers, seed companies and end-users,” said Jim Schweigert, president of Gro Alliance, which recently expanded its germplasm pool and secured a partnership with an advanced sorting technology company. Just as in soybeans, nutrient, and energy densification in PhotoSeed corn translates to more carbon captured in the seed. With higher oil production that does not require additional inputs or land, PhotoSeed becomes a sustainability embedded trait that has the potential to lower the carbon intensity score of the crop. “The future of agriculture must be grounded in innovation that democratizes value creation or else agriculture will not be responsive to demands for improved sustainability, nutrition, and energy,” said Chen. “Starting with the grower, our vision is to leverage trait technology and replicate our NewType model to ensure value creation and sharing across the entire supply chain.” PhotoSeed corn commercialization is expected in the 2027 growing season. For more information about ZeaKal and PhotoSeed technology, or to become part of the NewType model, visit zeakal.com. ABOUT ZEAKAL: At ZeaKal, we are building a value driven “NewType” of agriculture to harmonize the needs of farmers, consumers, and our planet. Our flagship plant trait technology, PhotoSeed™, helps crops capture more carbon and sunlight, leading to healthier, nutrient-rich food and feed grown on a smaller environmental footprint. We go beyond science to make affordable nutrition more sustainable, with marketable differentiation for growers. Discover how we are transforming carbon to nutrition: zeakal.com or @zeakal on Twitter. Contact Details AgTech PR for ZeaKal Jennifer Goldston jennifer@agtechpr.com Company Website https://www.zeakal.com

March 19, 2024 08:30 AM Central Daylight Time

Image

XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial

XORTX Therapeutics Inc.

New York, NY, March 19, 2024 – (Plato Data) -- In the realm of pharmaceutical innovation, XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), stands out for its significant achievements in 2023 and ambitious plans for 2024. XORTX, a late-stage clinical pharmaceutical firm specializing in revolutionary treatments for progressive kidney disease, has made headlines with its tremendous progress. Led by Dr. Allen Davidoff, XORTX celebrated a pivotal year in 2023, marked by substantial clinical, technological, and regulatory milestones. The company's proprietary oxypurinol formulation, XORLOTM, received FDA confirmation of eligibility for accelerated approval, a validation of its potential impact on kidney disease treatment. Moreover, XORTX secured Orphan Drug Designation for its XRx-008 program, specifically targeting Autosomal Dominant Polycystic Kidney Disease (ADPKD), further highlighting the company's dedication to addressing critical medical needs. A comprehensive summary of XORTX's achievements in 2023 reveals a strategic focus on chemistry, formulation, manufacturing, and pre-clinical studies. These efforts culminated in the preparation for a registration clinical trial, XRX-OXY-201, a crucial step towards market approval and value creation for XORTX and its stakeholders. Key highlights from 2023 include significant advancements in technology and patents, regulatory submissions to the FDA and European Medicines Agency (EMA), and organizational enhancements with strategic board appointments. Notably, XORTX's return to NASDAQ compliance underscores its commitment to transparent and robust corporate governance. Looking ahead to 2024, XORTX's objectives are clear: continue clinical and regulatory submissions, advance the lead program XRx-008 for ADPKD, and execute on strategic financing to fuel further growth and development. With a strong foundation established in 2023, XORTX is poised to make significant strides in the field of kidney disease therapeutics, potentially reshaping the landscape of patient care and pharmaceutical innovation. Investors can follow XORTX's progress here as it navigates the complex and dynamic healthcare industry, bringing hope and potential breakthroughs to kidney disease patients and investors alike. About PlatoAi Plato/Amplfi is an AI generated Global Press Release and Content Syndication Network. Plato’s Ai and advanced automation curates the latest sector intelligence with insights into the people, companies and culture driving innovation today. Source: Plato / Amplifi Contact Details Bryan Feinberg +1 551-574-2169

March 19, 2024 09:30 AM Eastern Daylight Time

Image

1 ... 326 327 328 329 330 ... 3750

Back